Evidence map›Paper›PMID 32791958›Full record

ArticleBMC nephrology2020

Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report.

Filippo Pinto E Vairo, Pavel N Pichurin, Fernando C Fervenza, Samih H Nasr, Kevin Mills, Christopher T Schmitz, Eric W Klee, Sandra M Herrmann

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Filippo Pinto E VairoCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Pavel N PichurinCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Fernando C FervenzaDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Samih H NasrDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kevin MillsUCL Institute of Child Health, Great Ormond Street Hospital, London, UK.
Christopher T SchmitzDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Eric W KleeCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Sandra M HerrmannDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Herrmann.sandra@mayo.edu.ORCID 0000-0002-3700-4537
Mayo Clinic · USMayo Clinic in Arizona · USGreat Ormond Street Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic changes in the LIM homeobox transcription factor 1 beta (LMX1B) have been associated with focal segmental glomerulosclerosis (FSGS) without the extra-renal or ultrastructural manifestations of Nail-patella syndrome (NPS) known as Nail-patella-like renal disease (NPLRD). Fabry disease (FD) is an X-linked lysosomal disease caused by the deficiency of alpha-galactosidase A. The classic form of the disease is characterized by acroparesthesia, angiokeratomas, cornea verticillata, hypertrophic cardiomyopathy, strokes, and chronic kidney disease. Podocyte myelin bodies on ultrastructural examination of kidney tissue are very characteristic of FD; however some medications and other conditions may mimic this finding. CASE PRESENTATION: Here, we report on a female patient with chronic kidney disease (CKD), positive family history for kidney disease and kidney biopsy showing a FSGS lesion and presence of focal myelin figures within podocytes concerning for FD. However, genetic testing for FD was negative. After comprehensive clinical, biochemical, and genetic evaluation, including whole exome and RNA sequencing, she was ultimately diagnosed with NPLRD.

conclusionsThis case illustrates the difficulties of diagnosing atypical forms of rare Mendelian kidney diseases and the role of a multidisciplinary team in an individualized medicine clinic setting in combination with state-of-the-art sequencing technologies to reach a definitive diagnosis.

Indexed as

Agedalpha-GalactosidaseDiagnosis, DifferentialFabry DiseaseFemaleGenetic TestingGlomerulosclerosis, Focal SegmentalHumansKidneyLIM-Homeodomain ProteinsNail-Patella SyndromeNephritis, HereditaryPodocytesTranscription Factorsalpha-GalactosidaseGLA protein, humanLIM homeobox transcription factor 1 betaLIM-Homeodomain ProteinsTranscription FactorsFabry diseaseIndividualized medicineLMX1BNail-patella-like renal disease

Identifiers

PMID32791958
PMCPMC7424659
OpenAlexW3049028580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.